Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT06394258
Eligibility Criteria:
Inclusion Criteria:
* Pathology proven adenocarcinoma of the endometrium
* National Comprehensive Cancer Network (NCCN) intermediate and high risk
* Unstaged patients with \< 50% myometrium invasion;
* Age ≥ 18;
* World health organization - Eastern Cooperative Oncology Group (WHO-ECOG) performance status 0-2 or Karnofsky performance status (KPS) ≥ 70;
* Hemoglobin ≥ 8.0 g/dl; white blood cells count (WBC) ≥ 1,500/mm3 ; Platelets ≥ 40,000 cells/mm3 .
* Signed informed consent
Exclusion Criteria:
* Evidence of post-surgical macroscopic residual disease;
* Patients with anatomical incompatibility with online tracking device;
* Psychiatric conditions;
* Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years;
* Prior radiation therapy to the pelvis that would result in overlap of radiation therapy fields;
* Severe active co-morbidities.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06394258
Study Brief:
Protocol Section:
NCT06394258